Chitosan Nanocarriers Loading Anti-Tumor Drugs

Abstract:

Chitosan is a kind of natural polymer commonly applied for nanomaterials, which is affluent in nature with favorable biodegradability and biocompatibility and free of toxicity or odor. In clinic it can be used as a drug carrier for the treatment of cancer, and also it is a kind of new pharmaceutical excipient. To prepare chitosan nanomaterial, various method are used, such as ionic crosslinking, covalent crosslinking, precipitation, free radical polymerization, reverse micelle, spray drying, and self-assembly. Furthermore, plenty of anti-tumor drugs, including adriamycin, epirubicin, taxol, 5-fluorouracil, norcantharidin, folic acid, and so on, are also attempted to load on these chitosan nanocarriers. In addition, the mechanism for those nanocarriers carrying anti-tumor drugs acting on tumor cell were explored, and the formulation mainly include electric charge adhesion effect, suppressing the proliferation of tumor cells, adjusting or enhancing immune ability of the body and inducing apoptosis. This paper compared the characteristics of different preparation methods on chitosan as a nanodrug carrier, summarized the types of packaged drugs, analyzed the mechanism of the chitosan as nanodrug carriers. It can provide valuable reference for researchers' further work.

• Periodical: Journal of Nano Research (Volume 32)
• Pages: 113-127
• DOI: https://doi.org/10.4028/www.scientific.net/JNanoR.32.113
• Online since: May 2015
• Authors: Ji Wei Wu, Xin Feng Song, Han Wen Sun*, Yan Cong Zhang, Xiang Ling Gu, Ping Xuan Dong, Shu Qin Cui, Chun Hua Fu
• Keywords: Anti-Tumor Drugs, Chitosan, Nanocarriers

References

[1] C. Dufes, A.G. Schatzlein, L. Tetley, A.I. Gray, D.G. Watson, J.C. Olivier, W. Couet, and I.F. Uchegbu, Niosomes and polymeric chitosan based vesicles bearing transferring and glucose ligands for drug targeting, Pharm Res, 17(2000)1250-1258.

DOI: 10.1023/b:pham.0000012156.65125.01

[2] D.L. Nettles, S.H. Elder, and J.A. Gilbert, Potential use of chitosan as a cell scaffold material for cartilage tissue engineering, Tissue Eng, 8(2002) 1009-1016.

DOI: 10.1089/107632702320934100

[3] X.Y. Cao, J.T. Liu, and M.Z. Yi, The research progress of antitumor drug carrier, Orthopaedic Biomechanics Materials and Clinical, 3(2006) 32-34.

[4] N.V. Majeti, and K. Ravi, A review of chitin and chitosan applications, React Funct Polym, 46(2000)1-27.

[5] J.Q. Qian, Y. Tang, and Z.X. Tang, Research on Preparation of Chitosan Nanoparticles from Triglycerides, Amina Acids & Biotic Resources, 30(2008)16-20.

[6] S. Mansouri, Y. Cuie, F. Winnik, Q. Shi, P. Lavigne, M. Benderdour, E. Beaumont, J.C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy , Biomaterials, 27(2006) 2060-(2065).

DOI: 10.1016/j.biomaterials.2005.09.020

[7] Y.Q. Xiao, C. Wang, and D.F. Yu, Study on Polyester Fabric Finishing with Ionic Liquid-Chitosan, Synth Fiber China, 41(2012) 21-24.

[8] F. Qian, F. Cui, J. Ding, T. Cui, and C.H. Yin, Chitosan graft copolymer nano carriers for oral protein drug delivery: preparation and characterization, Biomacromolecules, 7(2006)2722-2727.

DOI: 10.1021/bm060065f

[9] T.D. Jiang, Chitosan, Bei Jing: Chemical Industry Press, (2001)8-14.

[10] Y. Kato, H. Onishi, and Y. Machida, Application of chitin and chitosan derivatives in the pharmaceutical field, Curr Pharm Biotechno, 4(2003)303-309.

DOI: 10.2174/1389201033489748

[11] V. Dodane, and V.D. Vilivalam, Pharmaceutical applications of chitosan, Pharm Sci Tech Today, 1(1998) 246-253.

DOI: 10.1016/s1461-5347(98)00059-5

[12] C. Qin, Y. Du, L. Xiao, Z. Li, and X.H. Gao, Enzymic preparation of water-soluble chitosan and their antitumor activity, Int J Biol Macromol, 31(2002)111-117.

DOI: 10.1016/s0141-8130(02)00064-8

[13] S. Roller, N. Covill, The antifungal properties of chitosan in laboratory media and apple juice, Int J Food Microbiol, 47(1999) 67-77.

DOI: 10.1016/s0168-1605(99)00006-9

[14] S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabbhavi, Recent advances on chitosan-based micro and nanoparticles in drug delivery, J Control Rel, 100(2004)5-28.

[15] Z. Li, H.R. Ramay, K.D. Hauch, D. Xiao, M. Zhang, Chitosan-alginate hybrid scaffolds for bone tissue engineering, Biomaterials , 26(2005) 3919-3928.

DOI: 10.1016/j.biomaterials.2004.09.062

[16] Y. Cui. Modification of polysaccharide and study of sensitivity of polysaccharide hydrogel, Jilin: Changchun University of Science and Technology, (2013)1-127.

[17] Z.X. Zhuang, Z.Y. Lin, F.Q. Lu, Z.S. Cao, Y. Long, and Y.T. Li, Study of Chitosan Membrane on Biodegradation and tissue Regeneration, Chinese Journal of Dental Materials and Devices, 6(1997)178-180, 213.

[18] N. Minoura, T. Koyano, N. Koshizaki, H. Umehara, M. Nagura, K-i. Kobayashi, Preparation, properties, and cell attachment/growth behavior of PVA/chitosan-blended hydrogels, Materials Science and Engineering: C, 6(1998)275-280.

DOI: 10.1016/s0928-4931(98)00062-9

[19] M.X. Jin, and Q.H. Hu, Characterization and application in bioadhesive drug delivery system of chitosan, Centr South Pharm, 6(2008) 324–327.

[20] Z. Li, X.F. Liu, D.Z. Yang, Y.L. Guan, and K.D. Yao, Progress of Study on Degradation of Chitosan, Chemical Industry and Engineering Progress, (2000)20-23.

[21] K.L. Douglas, C.A. Piccirillo, and M. Tabrizian, Effects of alginate inclusion on the vector properties of chitosan-based nano carriers, J Control Release, 115(2006)354-361.

DOI: 10.1016/j.jconrel.2006.08.021

[22] Y.J. Song, Preparation, Exosyndrome and Application of Nano Drug Carrier Targeted to Brain Based on Macromolecular Polymer, Jiang Su: China University of Mining and Technology, (2012) 1-127.

[23] A.R. Dudhani, S.L. Kosaraju, Bioadhesive c Carbohydr Polym hitosan nano carriers: preparation and characterization, Carbohydr Polym, 81(2010)243–251.

DOI: 10.1016/j.carbpol.2010.02.026

[24] Y.M. Xu, W . Zhou, L. Yin, and H. Zheng, Preparation and bioadhesion of micro-gel of thiolated carboxymethyl chitosan, ournal of Clinical Rehabilitative Tissue Engineering Research, 13(2009)5645-5648.

[25] F.Y. Ding, Z. Nie, and H.B. Deng, Antibacterial hydrogel coating by electrophoretic co-deposition of chitosan/ alkynyl chitosan, Carbohydrate polymers , 98(2013)1547-1552.

DOI: 10.1016/j.carbpol.2013.07.042

[26] A.Y. Mansilla, L. Albertengo, M.S. Rodríguez, A. Debbaudt, A. Zúñiga, Evidence on antimicrobial properties and mode of action of a chitosan obtained from crustacean exoskeletons on Pseudomonas syringae pv. Tomato DC3000, Microbiology and Biotechnology, 97(2013).

DOI: 10.1007/s00253-013-4993-8

[27] A.L. Liao, X.P. Wu, S.T. Yi, and C.J. Deng, Study on Antimicrobial Activity of Chitosan against Staphylococcus aureus, Food and Nutrition in China, 17(2011)40-43.

[28] Y.J. Xie, X.F. Liu, and Q. Chen, Synthesis and characterization of water-soluble chitosan derivate and its antibacterial activity, Carbohydrate polymers, 69(2007) 142-147.

DOI: 10.1016/j.carbpol.2006.09.010

[29] C.Q. Qin, Q. Xiao, H.R. Li, M. Fang, Y. Liu, X.Y. Chen, and Q. Li, Calorimetric studies of the action of chitosan-N-2-hydroxypropyl trimethyl ammonium chloride on the growth of microorganisms, International journal of biological macromolecules. 34(2004).

DOI: 10.1016/j.ijbiomac.2004.03.009

[30] C.Q. Qin, H.R. Li, Q. Xiao, Y. Liu, J.C. Zhu, and Y.M. Du, Water-solubility of chitosan and its antimicrobial activity, Carbohydrate polymers , 63(2006)367-374.

DOI: 10.1016/j.carbpol.2005.09.023

[31] J.M. Huang, L.M. Wu, R.Y. Chen. Study on the regulation of chitin and chitosan to mice immune, Guangdong health and epidemic prevention, 25(1999) 4-6.

[32] P.G. Seferian, M. L．Martinez, Imune stimulating activity of two new chitosan containing adjuvant formulations, Vaccine, 19(2001) 661-668.

DOI: 10.1016/s0264-410x(00)00248-6

[33] T.J. Wei, D.G. Dong, L. Qiu, L.F. Yu, and X.D. Chen, Preparation of Chitosan Nanoparticles by Ionic Cross-Linking Method, Journal of Anhui Agri Sci， 40(2012)2885-2886, 2889.

[34] Z.H. Xing, and G.Z. Fang. Study on the Preparation of Folate-Chitosan microspheres by Ionic crosslinking, Heilongjiang Medicine Journal, 24(2011) 915-917.

[35] X.Y. Jiang, C.S. Zhou, J.S. Zhang, and J.Y. Yang, Study on the preparation of nanoparticles using sodium tripolyphosphate as cross-linking agent, China Journal of Modern Medicine , 13(2003)69-71.

[36] M. Amidi, E. Mastrobattista, W. Jiskoot, and W.E. Hennink, Chitosan-based delivery systems for protein therapeutics and antigens, Adv Drug Deliv Rev, 62(2010) 59-82.

DOI: 10.1016/j.addr.2009.11.009

[37] P.H. Yang, M. Liu, and J.Y. Zhang, Preparation and character of 5-fluorouracil/chitosan drug-loaded nanospheres, Chemical Research and Application, 21(2009)42-46.

[38] F. L. Mi, H.W. Sung, S.S. Shyu, C.C. Su, and C.K. Peng, Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads, Polymer， 44(2003)6521-6530.

DOI: 10.1016/s0032-3861(03)00620-7

[39] A.H. Krauland, and M.J. Alonso, Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system, Int J Pharm, 340(2007)134-142.

DOI: 10.1016/j.ijpharm.2007.03.005

[40] M. L Tsai, S.W. Bai, and R.H. Chen, Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle, Carbohyd Polym, 71(2008)448-457.

DOI: 10.1016/j.carbpol.2007.06.015

[41] M. Goldberg, R. Langer, and X. Jia, Nanostructured materials for applications in drug delivery and tissue engineering, J Biomater Sci Polym Ed 18(2007) 241-268.

[42] M. Bodnar, J.F. Hartmann, and J. Borbely, Preparation and characterization of chitosan-based nano carriers, Biomacromolecules, 6(2005)2521-2527.

DOI: 10.1021/bm0502258

[43] Y. Ohya，M. Shiratani，and H. Kobayashi, Release behavior of 5-fluorouracil from chitosan gel nanosphere immobilizing 5-fluorouracil coated with pdysaccharides and their cell specific cytotoxicity, Pure Apple Chem, 66(1994)629-642.

DOI: 10.1080/10601329408545334

[44] K.A. Janes, P. Calvo, and M.J. Alonso, Polysaccharide colloidal particles as delivery systems for macromolecule, Adv Drug Deliver Rev, 47(2001) 83-97.

DOI: 10.1016/s0169-409x(00)00123-x

[45] Y.K. Hao, and X.D. Yang, Progress of Study on Chitosan Loading Drugs, Chin Pharm J, 40(2005)1292-1295.

[46] A. Berthold, K. Cremer, and J. Kreuter, Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs, J Cont Rel, 39(1996)17-25.

DOI: 10.1016/0168-3659(95)00129-8

[47] X.X. Tian, and M.J. Groves, Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nano carriers, J Pharm Pharmacol, 51(1999) 151-157.

DOI: 10.1211/0022357991772268

[48] C. Chauvierre, D. Labarre, P. Couvreur, and C. Vauthier, Plug-in spectrometry with optical fbers as a novel analytical tool for nano carriers technology: application to the investigation of the emulsion polymerization of the alkylcyanoacrylate, J Nanopart Res, 5(2003).

[49] I. Bravo-Osuna, C. Vauthier, A. Farabollini, G.F. Palmieri, and G. Ponchel, Mucoadhesion mechanism of chitosan and thiolated chitosan-poly (isobutyl cyanoacrylate) core-shell nano carriers, Biomaterials, 28(2007) 2233–2243.

DOI: 10.1016/j.biomaterials.2007.01.005

[50] M.R. de Moura, F.A. Aouada, and L.H.C. Mattoso, Preparation of chitosan nano carriers using methacrylic acid, J Colloid Interface Sci, 321(2008)477–483.

DOI: 10.1016/j.jcis.2008.02.006

[51] S. Mitra, U. Gaur, P.C. Ghosh, A.N. Maitra, Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier, J Control Release, 74(2001)317-323.

DOI: 10.1016/s0168-3659(01)00342-x

[52] T. Banerjee, S. Mitra, A, Kumar Singh, R. Kumar Sharma, and A. Maitra, Preparation characterization and biodistribution of ultrafine chitosan nanoparticles, Int J Pharm. 243(2002) 93-105.

DOI: 10.1016/s0378-5173(02)00267-3

[53] H.Y. Huang, Y.T. Shieh, C.M. Shih, and Y.K. Twu, Magnetic chitosan/iron (II, III) oxide nano carriers prepared by spray-drying, Carbohydr Polym, 81(2010) 906–910.

DOI: 10.1016/j.carbpol.2010.04.003

[54] F.L. Mi, Y.C. Tna, H.F. Liang, and H.W. Sung, In vivo biocompatibility and degradability of a novel injecable-chiosan-based implant, Biomaterials, 23(2002)181-191.

DOI: 10.1016/s0142-9612(01)00094-1

[55] A. Grenha, C. Remuñán-López, E. L. Carvalho, and B. Seijo, Microspheres containing lipid / chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins, Euro J Pharm Biopharm, 69(2008)83-93.

DOI: 10.1016/j.ejpb.2007.10.017

[56] E. Gavini, G. Rassu, C. Muzzarelli, M. Cossu, and P. Giunchedi, Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide, Euro J Pharm Biopharm 68(2008)245-252.

DOI: 10.1016/j.ejpb.2007.05.002

[57] J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.W. Park, I.S. Kim, K. Kim, I.C. Kwon, Antitumor efficacy of cisplatin-loaded glycol chitosan nano carriers in tumor-bearing mice, J Control Release ，127(2008).

DOI: 10.1016/j.jconrel.2007.12.014

[58] M.R. Huo, J.P. Zhou, and Y. Zhang, Synthesis and characterization of novel amphiphilic chitosan derivatives and its solubilizing abilities for water insoluble drugs, Chem J Chinese U, 28(2007)1995–(1999).

[59] A.E. Sirica, R.J. Woodman, Selective aggregation of L1210 leukemia cells by the polycation chitosan, J Natl Cancer Inst, 47(1971) 377-388.

[60] J.H. Park, G. Saravanakumar, K. Kim, and I.C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives, Adv Drug Deliv Rev, 62(2010)28–41.

DOI: 10.1016/j.addr.2009.10.003

[61] Y. Liu, and H. Liu, Effect of chito oligosaccharide on the growth of human carcinoma of colon LoVo cell line, Acta Academiae Medicinae XuZhou, 22(2002)148-151.

[62] J.B. Shen, J.L. Lin, and S.F. Zhang, Study on the effect of Chitosan to cervical cancer HeLa, Acta Anatomica Sinica, 28(1997)421-423.

[63] S.H. Zhou, Y. Hong, G.J. Fang, Y.Y. Jiang, Y.Q. Bi, L.H. Yang, and Y. Chen, Preparation, characterization and anticancer effect of chitosan nanoparticles, Chinese Journal of Tissue Engineering Research, 11(2007)9688-9691.

[64] D.Y. Lee, I.S. Choi, J.H. Han, and H.S. Yoo, Chitosan and D-glucosamine induce expression of Th1 cytokine genes in porcine spleen cells, J Vet Med Sci ，64(2002)645-648.

DOI: 10.1292/jvms.64.645

[65] Z. Yu, L. Zhao, and H. Ke, Potential role of nuclear factor-kappa B in the induction of nitric oxide and tumor necrosis factor-alpha by oligo chitosan in macrophages, Int Immunopharmacol, 4(2004) 193-200.

DOI: 10.1016/j.intimp.2003.12.001

[66] Y. Maeda, and Y. Kimura, Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice, J Nutr, 134(2004)945-950.

DOI: 10.1093/jn/134.4.945

[67] S.J. Lee, P. Kyeongsoon, Y.K. Oh, S.H. Kwon, S. Her, I.S. Kim, K. Choi, S.J. Lee, H. Kim, S.G. Lee, K. Kim, and I.C. Kwon, Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice, Biomaterials, 30(2009).

DOI: 10.1016/j.biomaterials.2009.01.058

[68] K.A. Janes, M.P. Fresneau, A. Marazrela, A. Fabra, and M.J. Alonso, Chitosan nanoparticles as delivery systems for doxorubicin, J Control Release, 73(2001)255-267.

DOI: 10.1016/s0168-3659(01)00294-2

[69] M. Liu, J.Y. Zhang, P.H. Yang, and J.Y. Cai, Probing the inhibitory effect of 5-FuPCs drug-loaded nanospheres to human hepatoma cells with atomic force microscopy, Journal of Chinese Electron Microscopy Society, 28(2009)146-148.

[70] M. Hasegawa, K. Yagi, S. Iwakawa, and M. Hirai, Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells, Jpn J Cancer Res, 92(2001)459-466.

DOI: 10.1111/j.1349-7006.2001.tb01116.x

[71] H.O. Pae, W.G. Seo, N.Y. Kim, G.S. Oh, G.E. Kim, Y.H. Kim, H.J. Kwak, Y.G. Yun, C.D. Jun, and H.T. Chung, Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer, Leuk Res, 25(2001).

DOI: 10.1016/s0145-2126(00)00138-7

[72] D. Kumar, R.S. Tomar, S.K. Deolia, R. Srivastava, M. Mitra, and S. Tyagi, Isolation and characterization of degradation impurities in epirubicin hydrochloride injection, J Chromatogr B Analyt Technol Biomed Life Sci. 869(2008)45-53.

DOI: 10.1016/j.jchromb.2008.05.014

[73] D.R. Kalaria, G. Sharma, V. Beniwal, M.N. Ravi Kumar, Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats, Pharm Res, 26(2009)492-501.

DOI: 10.1007/s11095-008-9763-4

[74] J. Zhang, Self-assembled Nanoparticles Based on Oleoyl-chitosan as Antitumor Drug Carriers, ShanDong：Ocean University of China, (2010)1-132.

[75] H.L. Chen, The study of PLGA nanospheres surface modified with biotinylated chitosan as the antitumor drug delivery carriers, BeiJing: Peking Union Medical College, (2009)1-108.

[76] Y.Q. Ling, Characteristics of chitosan antitumor sustained-release drugs, Chinese Journal of Tissue Engineering Research, 17(2013)1489-1496.

[77] L.W. Guo, S.M. Wang, X.G. Hu, M.M. Cao, and J.R. Zhang, Study for preparation and anticancer activity of the stealth epirubicin chitosan nanoparticles, Basic& Clinical Medicine ，J.H. Kim, Y.S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S.Y. Jeong, R.W. Park, I.S. Kim, and I.C. Kwon, Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel, J CONTROL RELEASE, 111(2006).

DOI: 10.1016/j.jconrel.2005.12.013

[78] J.H. Kim, Y.S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S.Y. Jeong, R.W. Park, I.S. Kim, and I.C. Kwon, Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel, J Controll Release, 111(2006)228-234.

DOI: 10.1016/j.jconrel.2005.12.013

[79] Z.J. Liu, W.G. Zhang, J.G. Yu, G. Han, and H.G. Dai, Preparation, characterization and drug release property of paclitaxel nanoparticles, J Control Release, 13(2009)493-495.

[80] Y.L. Li, and W.F. Xu, The research progress of oral fluorouracil class anticancer drugs, Journal of Clinical Rehabilitative Tissue Engineering Research, 22(2001)323-326.

[81] Y.Y. Wang, The study of antitumor drug (5-fluorouracil) control-release, Pharmaceutical industry: synthetic medicine. Biochemical drugs. Preparation booklet, (2010)1-40.

[82] J.Y. Zhang Preparation and characterization of 5-Fluorouracil-loaded Chitosan nanoparticles, JiLin: Northeast Normal University, (2005)1-75.

[83] Q. Wang, l. Zhang, W. Hu, Z.H. Hu, and X.N. Zhang, Preparation and in Vitro Antineoplastic Activity of NorcantharidiN-Associated Galactosylated Chitosan Nanoparticles, Guangdong: Ji'nan University, 44(2009)913-919.

[84] C.C. Kuang, W. He, S.D. Luo, and J.C. Song, Study on the distribution and liver targeting of norcantharidin nanoparticles in mice, Chin Pharm J, 25(2005)527-530.

[85] S.D. Weitman, R.H. Lark, L.R. Coney, D.W. Fort, V. Frasca, V.R. Jr. Zurawski, and B.A. Kamen, Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Chin Hosp Pharm J. 52(1992)3396-3401.

[86] G. Toffoli, C. Cernigoi, A. Russo, A. Gallo, M. Bagnoli, and M. Boiocchi, Overexpression of folate binding protein in ovarian cancers, Cancer Res. 74(1997)193-198.

DOI: 10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f

[87] J. Sudimack, and R.J. Lee, Targeted drug delivery via the folate receptor, Int J Cancer. (2000)147-162.

DOI: 10.1016/s0169-409x(99)00062-9

[88] J.A. Reddy, and P.S. Low, Folate-mediated targeting of therapeutic and imaging agents to cancers, Adv Drug Deliv Rev. 15(1998)587-627.

[89] S. Liu, Study on the Preparation and Anti-Tumor Effect of Folate-conjugated Chitosan Nanoparticles, Crit Rev Ther Drug Carrier Syst, (2006)1-49.

[90] J.L. Gong, S.M. Wang, X.G. Hu, M.M. Cao, and J.R. Zhang, Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier, HuBei: Huazhong University of Science and Technology, 28(2008)2183-2186.